GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, ...

Medically classified as a glucagon-like peptide-1 (GLP-1 ... especially when starting Ozempic or increasing the dose, and vomiting may occur along with nausea. These usually subside after a ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

Glucagon-like peptide 1, or GLP-1 ... For instance, there have been reports of some patients experiencing nasty side effects, ...

GLP-1, or glucagon-like peptide-1, is a hormone produced in the body ... Liraglutide often causes nausea, vomiting, and ...

Each Baqsimi device includes 1 dose of glucagon and cannot be refused ... side effects reported with treatment include nausea, vomiting, headache, upper respiratory tract irritation, and nasal ...

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic procedures,” said Kevin McCulloch, President and COO of Xeris. “American Regent is the ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.